000 | 01922 a2200517 4500 | ||
---|---|---|---|
005 | 20250516220526.0 | ||
264 | 0 | _c20140909 | |
008 | 201409s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/WNL.0000000000000615 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKaufmann, Horacio | |
245 | 0 | 0 |
_aDroxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. _h[electronic resource] |
260 |
_bNeurology _cJul 2014 |
||
300 |
_a328-35 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAutonomic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAutonomic Nervous System Diseases _xcomplications |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aDizziness _xdrug therapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDroxidopa _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypotension, Orthostatic _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple System Atrophy _xcomplications |
650 | 0 | 4 |
_aNervous System Diseases _xcomplications |
650 | 0 | 4 |
_aParkinson Disease _xcomplications |
650 | 0 | 4 | _aPosture |
650 | 0 | 4 |
_aPure Autonomic Failure _xcomplications |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aFreeman, Roy | |
700 | 1 | _aBiaggioni, Italo | |
700 | 1 | _aLow, Phillip | |
700 | 1 | _aPedder, Simon | |
700 | 1 | _aHewitt, L Arthur | |
700 | 1 | _aMauney, Joe | |
700 | 1 | _aFeirtag, Michael | |
700 | 1 | _aMathias, Christopher J | |
773 | 0 |
_tNeurology _gvol. 83 _gno. 4 _gp. 328-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000000615 _zAvailable from publisher's website |
999 |
_c23932994 _d23932994 |